Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Hepatitis

Free Subscription Articles published in Arch Virol Retrieve available abstracts of 101 articles: HTML format

Single Articles

July 2021
1. NASIMZADEH S, Azaran A, Jalilian S, Makvandi M, et al
   Prevalence of occult hepatitis C virus infection in beta-thalassemia major patients in Ahvaz, Iran.
   Arch Virol. 2021 Jul 18. pii: 10.1007/s00705-021-05126.
   PubMed     Abstract available
   
   
   
2. MIRI HH, Fazeli P, Ali-Hassanzadeh M, Bemani P, et al
   Correlation between IL-28 polymorphism and spontaneous clearance in HCV patients: systematic review and meta-analysis.
   Arch Virol. 2021 Jul 3. pii: 10.1007/s00705-021-05141.
   PubMed     Abstract available
   
   
   June 2021
3. PORTILHO MM, Bezerra CS, Mendonca ACDF, Marques VA, et al
   Applicability of oral fluid samples for tracking hepatitis B virus mutations, genotyping, and phylogenetic analysis.
   Arch Virol. 2021 Jun 19. pii: 10.1007/s00705-021-05122.
   PubMed     Abstract available
   
   
   May 2021
4. LI Y, Miao Z, Li P, Zhang R, et al
   Ivermectin effectively inhibits hepatitis E virus replication, requiring the host nuclear transport protein importin alpha1.
   Arch Virol. 2021 May 14. pii: 10.1007/s00705-021-05096.
   PubMed     Abstract available
   
   
   
5. DE PINA-ARAUJO IIM, Horta MA, do Amaral Mello FC, Soares CC, et al
   Human pegivirus 1 in Cabo Verde: prevalence and genotypic distribution among HIV-infected individuals.
   Arch Virol. 2021;166:1345-1353.
   PubMed     Abstract available
   
   
   April 2021
6. LI MH, Lu Y, Sun FF, Chen QQ, et al
   Transforming growth factor beta as a possible independent factor in chronic hepatitis B.
   Arch Virol. 2021 Apr 19. pii: 10.1007/s00705-021-05062.
   PubMed     Abstract available
   
   
   
7. ALI NA, Hamdy NM, Gibriel AA, El Mesallamy HO, et al
   Investigation of the relationship between CTLA4 and the tumor suppressor RASSF1A and the possible mediating role of STAT4 in a cohort of Egyptian patients infected with hepatitis C virus with and without hepatocellular carcinoma.
   Arch Virol. 2021 Apr 1. pii: 10.1007/s00705-021-04981.
   PubMed     Abstract available
   
   
   February 2021
8. BOGLIONE L, De Benedetto I, Lupia T, Cusato J, et al
   Serological and virological response in patients with hepatitis B virus genotype E treated with entecavir or tenofovir: a prospective study.
   Arch Virol. 2021 Feb 12. pii: 10.1007/s00705-021-04992.
   PubMed     Abstract available
   
   
   
9. ABD ALLA MDA, Dawood RM, Rashed HAE, Farrag G, et al
   Treatment of hepatitis C virus infection with direct-acting antivirals plus ribavirin eliminates viral RNA from peripheral blood mononuclear cells and reduces virologic relapse in diverse hepatic parenchymal changes.
   Arch Virol. 2021 Feb 3. pii: 10.1007/s00705-021-04969.
   PubMed     Abstract available
   
   
   
10. RAUFF B, Amar A, Chudhary SA, Mahmood S, et al
    Interferon-lambda rs12979860 genotype association with liver fibrosis in chronic hepatitis C (CHC) patients in the Pakistani population.
    Arch Virol. 2021 Feb 2. pii: 10.1007/s00705-020-04901.
    PubMed     Abstract available
    
    
    January 2021
11. MO L, Zeng Z, Deng R, Li Z, et al
    Hepatitis A virus-induced hsa-miR-146a-5p attenuates IFN-beta signaling by targeting adaptor protein TRAF6.
    Arch Virol. 2021 Jan 18. pii: 10.1007/s00705-021-04952.
    PubMed     Abstract available
    
    
    
12. CHOUIKHA A, Khedhiri M, Triki H, Hammemi W, et al
    Focus on hepatitis C virus genotype distribution in Tunisia prior to elimination: a 16-year retrospective study.
    Arch Virol. 2021 Jan 4. pii: 10.1007/s00705-020-04918.
    PubMed     Abstract available
    
    
    September 2020
13. FOUAD HM, Ahmed A, Reyad EM, ElSadek SM, et al
    Correction to: Hepatitis D virus seroprevalence in Egyptian HBsAgpositive children: a singlecenter study.
    Arch Virol. 2020 Sep 11. pii: 10.1007/s00705-020-04804.
    PubMed     Abstract available
    
    
    
14. CAZARES-CORTAZAR A, Uribe-Noguez LA, Mata-Marin JA, Gaytan-Martinez J, et al
    A decrease in hepatitis C virus RNA to undetectable levels in chronic hepatitis C patients after PegIFNalpha + RVB or sofosbuvir + NS5A inhibitor treatment is associated with decreased insulin resistance and persistent oxidative stress.
    Arch Virol. 2020 Sep 3. pii: 10.1007/s00705-020-04797.
    PubMed     Abstract available
    
    
    August 2020
15. FOUAD HM, Ahmed A, Reyad EM, ElSadek SM, et al
    Hepatitis D virus seroprevalence in Egyptian HBsAg-positive children: a single-center study.
    Arch Virol. 2020 Aug 3. pii: 10.1007/s00705-020-04757.
    PubMed     Abstract available
    
    
    July 2020
16. SAFARNEZHAD TAMESHKEL F, Karbalaie Niya MH, Zamani F, Motamed N, et al
    Resistance-associated substitutions (RASs) to HCV direct-acting antivirals (DAAs) at baseline of treatment in thalassemia patients: a referral center study.
    Arch Virol. 2020 Jul 8. pii: 10.1007/s00705-020-04728.
    PubMed     Abstract available
    
    
    
17. RASHTI R, Alavian SM, Moradi Y, Sharafi H, et al
    Global prevalence of HCV and/or HBV coinfections among people who inject drugs and female sex workers who live with HIV/AIDS: a systematic review and meta-analysis.
    Arch Virol. 2020 Jul 2. pii: 10.1007/s00705-020-04716.
    PubMed     Abstract available
    
    
    June 2020
18. NIE B, Guo Y, Zhang K, Liu J, et al
    Analysis of drug-resistance-associated mutations and genetic barriers in hepatitis C virus NS5B sequences in China.
    Arch Virol. 2020 Jun 29. pii: 10.1007/s00705-020-04713.
    PubMed     Abstract available
    
    
    
19. MAK D, Kramvis A
    Molecular characterization of hepatitis B virus isolated from Black South African cancer patients, with and without hepatocellular carcinoma.
    Arch Virol. 2020 Jun 5. pii: 10.1007/s00705-020-04686.
    PubMed     Abstract available
    
    
    May 2020
20. LI Y, Shen C, Yang L, Yang Y, et al
    Correction to: Intra-host diversity of hepatitis B virus during mother-to-child transmission: the X gene may play a key role in virus survival in children after transmission.
    Arch Virol. 2020 May 6. pii: 10.1007/s00705-020-04636.
    PubMed     Abstract available
    
    
    April 2020
21. SAID EM, Abdulaziz BA, El Kassas M, El Attar IH, et al
    High success rates for the use of sofosbuvir/ombitasvir/paritaprevir/ritonavir + ribavirin and sofosbuvir/simeprevir/daclatasvir + ribavirin in retreatment of chronic hepatitis C infection after unsuccessful sofosbuvir/daclatasvir therapy: a real-life
    Arch Virol. 2020 Apr 30. pii: 10.1007/s00705-020-04639.
    PubMed     Abstract available
    
    
    
22. LI Y, Shen C, Yang L, Yang Y, et al
    Intra-host diversity of hepatitis B virus during mother-to-child transmission: the X gene may play a key role in virus survival in children after transmission.
    Arch Virol. 2020 Apr 2. pii: 10.1007/s00705-020-04597.
    PubMed     Abstract available
    
    
    March 2020
23. FITE RO, Kooti W, Azeze GA, Tesfaye B, et al
    Seroprevalence and factors associated with hepatitis B virus infection in blood donors in Ethiopia: a systematic review and meta-analysis.
    Arch Virol. 2020 Mar 26. pii: 10.1007/s00705-020-04591.
    PubMed     Abstract available
    
    
    February 2020
24. SHAHID M, Idrees M, Butt AM, Raza SM, et al
    Blood-based gene expression profile of oxidative stress and antioxidant genes for identifying surrogate markers of liver tissue injury in chronic hepatitis C patients.
    Arch Virol. 2020 Feb 27. pii: 10.1007/s00705-020-04564.
    PubMed     Abstract available
    
    
    
25. VILLAR LM, de Paula VS, do Lago BV, Miguel JC, et al
    Epidemiology of hepatitis B and C virus infection in Central West Argentina.
    Arch Virol. 2020 Feb 20. pii: 10.1007/s00705-020-04540.
    PubMed     Abstract available
    
    
    
26. OLIVERA S, Perez A, Falcon V, Urquiza D, et al
    Protective cellular immune response against hepatitis C virus elicited by chimeric protein formulations in BALB/c mice.
    Arch Virol. 2020 Feb 3. pii: 10.1007/s00705-019-04464.
    PubMed     Abstract available
    
    
    January 2020
27. PATEL J, Sharma P
    Design of a novel rapid immunoassay for simultaneous detection of hepatitis C virus core antigen and antibodies.
    Arch Virol. 2020 Jan 21. pii: 10.1007/s00705-019-04518.
    PubMed     Abstract available
    
    
    
28. CHOOBIN H, Bamdad T, Shekarabi M
    The pattern of antiviral protein expression induced by interferon lambda1 in peripheral blood mononuclear cells of patients with chronic hepatitis C virus infection.
    Arch Virol. 2020 Jan 11. pii: 10.1007/s00705-019-04438.
    PubMed     Abstract available
    
    
    
29. REN Y, Xu Y, Lee WM, Di Bisceglie AM, et al
    In-depth serum virome analysis in patients with acute liver failure with indeterminate etiology.
    Arch Virol. 2020;165:127-135.
    PubMed     Abstract available
    
    
    December 2019
30. KATO N, Ueda Y, Sejima H, Gu W, et al
    Study of multiple genetic variations caused by persistent hepatitis C virus replication in long-term cell culture.
    Arch Virol. 2019 Dec 12. pii: 10.1007/s00705-019-04461.
    PubMed     Abstract available
    
    
    
31. DA SILVA MS, Weber MN, Baumbach LF, Cibulski SP, et al
    Highly divergent cattle hepacivirus N in Southern Brazil.
    Arch Virol. 2019;164:3133-3136.
    PubMed     Abstract available
    
    
    November 2019
32. SAHINDOKUYUCU I, Coven F, Kilic H, Yilmaz O, et al
    Correction to: First report of fowl aviadenovirus serotypes FAdV-8b and FAdV-11 associated with inclusion body hepatitis in commercial broiler and broiler-breeder flocks in Turkey.
    Arch Virol. 2019 Nov 27. pii: 10.1007/s00705-019-04467.
    PubMed     Abstract available
    
    
    
33. RYLL R, Heckel G, Corman VM, Drexler JF, et al
    Genomic and spatial variability of a European common vole hepevirus.
    Arch Virol. 2019;164:2671-2682.
    PubMed     Abstract available
    
    
    
34. SAHINDOKUYUCU I
    First report of fowl aviadenovirus serotypes FAdV-8b and FAdV-11 associated with inclusion body hepatitis in commercial broiler and broiler-breeder flocks in Turkey.
    Arch Virol. 2019 Nov 1. pii: 10.1007/s00705-019-04449.
    PubMed     Abstract available
    
    
    October 2019
35. DHIFALLAH I, Khedhiri M, Chouikha A, Kharroubi G, et al
    Hepatitis viruses take advantage of traditional practices to increase the burden of hepatocellular carcinoma in Tunisia.
    Arch Virol. 2019 Oct 19. pii: 10.1007/s00705-019-04440.
    PubMed     Abstract available
    
    
    September 2019
36. ZHOU K, Zhou Q, Yang D, Yue H, et al
    Hepatitis E virus in Tibetan pigs on the Qinghai-Tibetan Plateau: detection, molecular characterization and infection of BALB/c mice.
    Arch Virol. 2019 Sep 23. pii: 10.1007/s00705-019-04410.
    PubMed     Abstract available
    
    
    
37. YANG JJ, Fan HZ, Tian T, Wu MP, et al
    Impact of CYP2R1, CYP27A1 and CYP27B1 genetic polymorphisms controlling vitamin D metabolism on susceptibility to hepatitis C virus infection in a high-risk Chinese population.
    Arch Virol. 2019 Sep 13. pii: 10.1007/s00705-019-04378.
    PubMed     Abstract available
    
    
    August 2019
38. GAO M, Feng C, Ying R, Nie Y, et al
    A novel one-step quantitative reverse transcription PCR assay for selective amplification of hepatitis B virus pregenomic RNA from a mixture of HBV DNA and RNA in serum.
    Arch Virol. 2019 Aug 19. pii: 10.1007/s00705-019-04372.
    PubMed     Abstract available
    
    
    
39. PONDE RAA
    Expression and detection of anti-HBs antibodies after hepatitis B virus infection or vaccination in the context of protective immunity.
    Arch Virol. 2019 Aug 9. pii: 10.1007/s00705-019-04369.
    PubMed     Abstract available
    
    
    
40. HUSSEINI AA, Saeed KMI, Yurdcu E, Sertoz R, et al
    Epidemiology of blood-borne viral infections in Afghanistan.
    Arch Virol. 2019;164:2083-2090.
    PubMed     Abstract available
    
    
    July 2019
41. DONYAVI T, Bokharaei-Salim F, Khanaliha K, Sheikh M, et al
    High prevalence of occult hepatitis C virus infection in injection drug users with HIV infection.
    Arch Virol. 2019 Jul 25. pii: 10.1007/s00705-019-04353.
    PubMed     Abstract available
    
    
    
42. PRATA TVG, Silva DSRD, Manchiero C, Dantas BP, et al
    MTTP polymorphisms and hepatic steatosis in individuals chronically infected with hepatitis C virus.
    Arch Virol. 2019 Jul 18. pii: 10.1007/s00705-019-04352.
    PubMed     Abstract available
    
    
    
43. DOGADOV DI, Korzaya LI, Kyuregyan KK, Karlsen AA, et al
    Natural infection of captive cynomolgus monkeys (Macaca fascicularis) with hepatitis E virus genotype 4.
    Arch Virol. 2019 Jul 3. pii: 10.1007/s00705-019-04337.
    PubMed     Abstract available
    
    
    
44. LIMERES MJ, Gomez ER, Noseda DG, Cerrudo CS, et al
    Impact of hepatitis B virus genotype F on in vitro diagnosis: detection efficiency of HBsAg from Amerindian subgenotypes F1b and F4.
    Arch Virol. 2019 Jul 2. pii: 10.1007/s00705-019-04332.
    PubMed     Abstract available
    
    
    June 2019
45. BETTAIEB J, Chouikha A, Khedhiri M, Kharroubi G, et al
    Hepatitis C virus epidemiology in Central-West Tunisia: a population-based cross-sectional study.
    Arch Virol. 2019 Jun 10. pii: 10.1007/s00705-019-04308.
    PubMed     Abstract available
    
    
    May 2019
46. TIAN Z, Wang M, Yao N, Yang S, et al
    Expression of autophagy-modulating genes in peripheral blood mononuclear cells from familial clustering patients with chronic hepatitis B virus infection.
    Arch Virol. 2019 May 17. pii: 10.1007/s00705-019-04248.
    PubMed     Abstract available
    
    
    
47. WANG M, Liao Q, Xu R, Song D, et al
    Hepatitis C virus 3b strains in injection drug users in Guangdong Province, China, may have originated in Yunnan Province.
    Arch Virol. 2019 May 7. pii: 10.1007/s00705-019-04260.
    PubMed     Abstract available
    
    
    April 2019
48. MEKKY RY, El-Ekiaby N, El Sobky SA, Elemam NM, et al
    Epigallocatechin gallate (EGCG) and miR-548m reduce HCV entry through repression of CD81 receptor in HCV cell models.
    Arch Virol. 2019 Apr 4. pii: 10.1007/s00705-019-04232.
    PubMed     Abstract available
    
    
    March 2019
49. DEBAT HJ, Ng TFF
    Complete genome sequence of a divergent strain of Tibetan frog hepatitis B virus associated with a concave-eared torrent frog (Odorrana tormota).
    Arch Virol. 2019 Mar 28. pii: 10.1007/s00705-019-04227.
    PubMed     Abstract available
    
    
    
50. PAUL C, Khera L, Kaul R
    Hepatitis C virus core protein interacts with cellular metastasis suppressor Nm23-H1 and promotes cell migration and invasion.
    Arch Virol. 2019 Mar 11. pii: 10.1007/s00705-019-04151.
    PubMed     Abstract available
    
    
    
51. PENG TT, Cai QE, Yang M, Chen SP, et al
    Epidemiological trends and virological traits of hepatitis B virus infection in pregnant women and neonates.
    Arch Virol. 2019 Mar 8. pii: 10.1007/s00705-019-04190.
    PubMed     Abstract available
    
    
    February 2019
52. SCHLOTTAU K, Fereidouni S, Beer M, Hoffmann B, et al
    Molecular identification and characterization of nonprimate hepaciviruses in equines.
    Arch Virol. 2019;164:391-400.
    PubMed     Abstract available
    
    
    January 2019
53. DENG H, Liang S, Liu H, Xu M, et al
    Genetic characterization of a novel unique recombinant form of HIV-1 originating from subtype A1 and C in Guangdong Province, China.
    Arch Virol. 2019;164:285-290.
    PubMed     Abstract available
    
    
    December 2018
54. ZANG F, Yue M, Zhuo L, Wu J, et al
    Correction to: Association of CXCR2 genotype variations with HCV clearance in a Chinese population.
    Arch Virol. 2018 Dec 8. pii: 10.1007/s00705-018-4111.
    PubMed     Abstract available
    
    
    November 2018
55. SEVIC I, Elizalde MM, Gonzalez Lopez Ledesma MM, Flichman DM, et al
    Analysis of fitness differences of hepatitis B virus genotypes D and F using a cotransfection assay.
    Arch Virol. 2018 Nov 12. pii: 10.1007/s00705-018-4090.
    PubMed     Abstract available
    
    
    
56. CHEN L, Zhang Y, Zhang S, Chen Y, et al
    A novel T-cell epitope in the transmembrane region of the hepatitis B virus envelope protein responds upon dendritic cell expansion.
    Arch Virol. 2018 Nov 10. pii: 10.1007/s00705-018-4095.
    PubMed     Abstract available
    
    
    
57. MATCZUK AK, Cwiek K, Wieliczko A
    Avian hepatitis E virus is widespread among chickens in Poland and belongs to genotype 2.
    Arch Virol. 2018 Nov 3. pii: 10.1007/s00705-018-4089.
    PubMed     Abstract available
    
    
    
58. SHEIKH M, Bokharaei-Salim F, Monavari SH, Ataei-Pirkooh A, et al
    Molecular diagnosis of occult hepatitis C virus infection in Iranian injection drug users.
    Arch Virol. 2018 Nov 2. pii: 10.1007/s00705-018-4066.
    PubMed     Abstract available
    
    
    October 2018
59. LI D, Chen Q, Tao C
    BCP/PC mutation prevalence and their association with HBV replication in HIV/HBV co-infected patients.
    Arch Virol. 2018;163:2829-2833.
    PubMed     Abstract available
    
    
    September 2018
60. HOFFMANN TW, Delfosse F, Helle F, Francois C, et al
    Correction to: The expression of HCV-associated host factors is dependent on the hepatoma cell line used in HCV studies.
    Arch Virol. 2018 Sep 27. pii: 10.1007/s00705-018-4044.
    PubMed     Abstract available
    
    
    
61. TANG WF, Kong DG, Wang YH, Liu MQ, et al
    Hepatitis E virus infection in Wuhan, Central China.
    Arch Virol. 2018 Sep 18. pii: 10.1007/s00705-018-4036.
    PubMed     Abstract available
    
    
    
62. MIRAZO S, D Albora C, Quintero Gil D, Cabrera K, et al
    A case of incidental infection of Hepatitis E virus (HEV) genotype 1 in a domestic pig.
    Arch Virol. 2018 Sep 15. pii: 10.1007/s00705-018-4025.
    PubMed     Abstract available
    
    
    July 2018
63. ABD ALLA MDA, El Awady MK, Dawood RM, Elhawary MA, et al
    Hepatitis C virus serologic relapse after treatment with direct-acting antivirals is dependent on viral RNA levels in peripheral blood mononuclear cells and the grade of liver cirrhosis.
    Arch Virol. 2018 Jul 3. pii: 10.1007/s00705-018-3922.
    PubMed     Abstract available
    
    
    
64. YANG C, Wang L, Shen H, Zheng Y, et al
    Detection and genomic characterization of new avian-like hepatitis E virus in a sparrow in the United States.
    Arch Virol. 2018 Jul 3. pii: 10.1007/s00705-018-3925.
    PubMed     Abstract available
    
    
    
65. YACOUBI L, Brichler S, Le Gal F, Triki H, et al
    Molecular characterization of the full-length genome sequences of HDV strains circulating in Tunisia.
    Arch Virol. 2018;163:1727-1731.
    PubMed     Abstract available
    
    
    June 2018
66. MOREIRA RC, de Torres Santos AP, Lisboa-Neto G, Mendes-Correa MCJ, et al
    Prevalence of naturally occurring amino acid substitutions associated with resistance to hepatitis C virus NS3/NS4A protease inhibitors in Sao Paulo state.
    Arch Virol. 2018 Jun 30. pii: 10.1007/s00705-018-3920.
    PubMed     Abstract available
    
    
    
67. ZANG F, Yue M, Zhuo L, Wu J, et al
    Association of CXCR2 genotype variations with HCV clearance in a Chinese population.
    Arch Virol. 2018 Jun 8. pii: 10.1007/s00705-018-3872.
    PubMed     Abstract available
    
    
    
68. HAMDY S, Osman AM, Zakaria ZA, Galal I, et al
    Association of Toll-like receptor 3 and Toll-like receptor 9 single-nucleotide polymorphisms with hepatitis C virus persistence among Egyptians.
    Arch Virol. 2018 Jun 2. pii: 10.1007/s00705-018-3893.
    PubMed     Abstract available
    
    
    
69. TAJIK Z, Bokharaei-Salim F, Ghorbani S, Keyvani H, et al
    Detection of HBV genome in the plasma and peripheral blood mononuclear cells of Iranian HBsAg negative patients with HIV infection: occult HBV infection.
    Arch Virol. 2018;163:1559-1566.
    PubMed     Abstract available
    
    
    May 2018
70. SULCZEWSKI FB, Liszbinski RB, Romao PRT, Rodrigues Junior LC, et al
    Nanoparticle vaccines against viral infections.
    Arch Virol. 2018 May 4. pii: 10.1007/s00705-018-3856.
    PubMed     Abstract available
    
    
    March 2018
71. ELHELW DS, Riad SE, Shawer H, El-Ekiaby N, et al
    Correction to: Ectopic delivery of miR-200c diminishes hepatitis C virus infectivity through transcriptional and translational repression of Occludin.
    Arch Virol. 2018 Mar 24. pii: 10.1007/s00705-018-3798.
    PubMed     Abstract available
    
    
    
72. FRAGOSO-FONSECA DE, Escobar-Escamilla N, Lloret Y Sanchez LT, Wong-Arambula CE, et al
    Full genome and phylogenetic analysis of hepatitis B virus genotype F in Mexican isolates.
    Arch Virol. 2018 Mar 16. pii: 10.1007/s00705-018-3813.
    PubMed     Abstract available
    
    
    February 2018
73. MOZHGANI SH, Malekpour SA, Norouzi M, Ramezani F, et al
    Molecular evolution and phylodynamics of hepatitis B virus infection circulating in Iran.
    Arch Virol. 2018 Feb 13. pii: 10.1007/s00705-018-3764.
    PubMed     Abstract available
    
    
    
74. WANG H, Xin X, Wang M, Han L, et al
    Myxovirus resistance protein A inhibits hepatitis C virus replication through JAK-STAT pathway activation.
    Arch Virol. 2018 Feb 7. pii: 10.1007/s00705-018-3748.
    PubMed     Abstract available
    
    
    
75. BEHZADIFAR M, Gorji HA, Bragazzi NL
    The prevalence of hepatitis C virus infection in thalassemia patients in Iran from 2000 to 2017: a systematic review and meta-analysis.
    Arch Virol. 2018 Feb 6. pii: 10.1007/s00705-018-3767.
    PubMed     Abstract available
    
    
    
76. PRIMADHARSINI PP, Mulyanto, Wibawa IDN, Anggoro J, et al
    The identification and characterization of novel rat hepatitis E virus strains in Bali and Sumbawa, Indonesia.
    Arch Virol. 2018 Feb 5. pii: 10.1007/s00705-018-3736.
    PubMed     Abstract available
    
    
    
77. ZHU DY, Deng XZ, Zhu YM, Li GT, et al
    Association of IL-28B, TBX21 gene polymorphisms and predictors of virological response for chronic hepatitis C.
    Arch Virol. 2018 Feb 5. pii: 10.1007/s00705-018-3750.
    PubMed     Abstract available
    
    
    January 2018
78. YU JM, Li LL, Xie GC, Zhang CY, et al
    Experimental infection of Marmota monax with a novel hepatitis A virus.
    Arch Virol. 2018 Jan 31. pii: 10.1007/s00705-018-3715.
    PubMed     Abstract available
    
    
    
79. NAEEMI H, Aslam R, Raza SM, Shahzad MA, et al
    Distribution of IL28B and IL10 polymorphisms as genetic predictors of treatment response in Pakistani HCV genotype 3 patients.
    Arch Virol. 2018 Jan 16. pii: 10.1007/s00705-018-3711.
    PubMed     Abstract available
    
    
    
80. YAN Y, Li C, Sun B, Yang R, et al
    DCAF1 is involved in HCV replication through regulation of miR-122.
    Arch Virol. 2018 Jan 11. pii: 10.1007/s00705-017-3691.
    PubMed     Abstract available
    
    
    
81. BOGLIONE L, Cusato J, Pinna SM, De Nicolo A, et al
    Role of ribavirin in the treatment of hepatitis C virus-associated mixed cryoglobulinemia with interferon-free regimens.
    Arch Virol. 2018 Jan 9. pii: 10.1007/s00705-017-3684.
    PubMed     Abstract available
    
    
    December 2017
82. ISHIBASHI M, Yamaguchi H, Hirotani Y, Sakurada A, et al
    Contradictory intrahepatic immune responses activated in high-load hepatitis C virus livers compared with low-load livers.
    Arch Virol. 2017 Dec 16. pii: 10.1007/s00705-017-3675.
    PubMed     Abstract available
    
    
    
83. HARA J, Tanaka Y, Kaneko H, Itoh Y, et al
    Detection of hepatitis B virus DNA and HBsAg from postmortem blood and bloodstains.
    Arch Virol. 2017 Dec 2. pii: 10.1007/s00705-017-3665.
    PubMed     Abstract available
    
    
    November 2017
84. SILVA FQ, Santos FJA, Andrade AP, Pacheco SDB, et al
    Hepatitis C virus infection among illicit drug users in an archipelago of the Amazon.
    Arch Virol. 2017 Nov 21. doi: 10.1007/s00705-017-3656.
    PubMed     Abstract available
    
    
    
85. YANG S, Xing H, Feng S, Ju W, et al
    Prevalence of NS5B resistance-associated variants in treatment-naive Asian patients with chronic hepatitis C.
    Arch Virol. 2017 Nov 15. doi: 10.1007/s00705-017-3640.
    PubMed     Abstract available
    
    
    
86. GORI A, Gheorgita S, Spinu C, Pinzaru I, et al
    Hepatitis B, C and D virus genotypes detected in HBsAg- or anti-HCV-positive people from the Republic of Moldova.
    Arch Virol. 2017 Nov 8. doi: 10.1007/s00705-017-3632.
    PubMed     Abstract available
    
    
    
87. DE MIRANDA BKB, de Sa KSG, da Silva ANR, Feitosa RNM, et al
    GBV-C/HIV-1 coinfection is associated with low HIV-1 viral load and high CD4+ T lymphocyte count.
    Arch Virol. 2017;162:3431-3438.
    PubMed     Abstract available
    
    
    October 2017
88. BADFAR G, Shohani M, Nasirkandy MP, Mansouri A, et al
    Epidemiology of hepatitis B in pregnant Iranian women: a systematic review and meta-analysis.
    Arch Virol. 2017 Oct 23. doi: 10.1007/s00705-017-3551.
    PubMed     Abstract available
    
    
    
89. NGUYEN LT, Van Nguyen D, Carr MJ, Hall WW, et al
    Association of interferon lambda polymorphisms with elevated baseline viral loads in chronic hepatitis C virus genotype 6 infection.
    Arch Virol. 2017 Oct 11. doi: 10.1007/s00705-017-3583.
    PubMed     Abstract available
    
    
    
90. ABD-ELSALAM S, Sharaf-Eldin M, Soliman S, Elfert A, et al
    Efficacy and safety of sofosbuvir plus ribavirin for treatment of cirrhotic patients with genotype 4 hepatitis C virus in real-life clinical practice.
    Arch Virol. 2017 Oct 5. doi: 10.1007/s00705-017-3573.
    PubMed     Abstract available
    
    
    September 2017
91. FERREIRA AC, Gomes-Gouvea MS, Lisboa-Neto G, Mendes-Correa MCJ, et al
    Serological and molecular markers of hepatitis E virus infection in HIV-infected patients in Brazil.
    Arch Virol. 2017 Sep 30. doi: 10.1007/s00705-017-3562.
    PubMed     Abstract available
    
    
    
92. RAMIREZ-SOTO MC, Bracho MA, Gonzalez-Candelas F, Huichi-Atamari M, et al
    Genotypes and subgenotypes of hepatitis B virus circulating in an endemic area in Peru.
    Arch Virol. 2017 Sep 25. doi: 10.1007/s00705-017-3557.
    PubMed     Abstract available
    
    
    
93. PONDE RAA
    The serological markers of acute infection with hepatitis A, B, C, D, E and G viruses revisited.
    Arch Virol. 2017 Sep 7. doi: 10.1007/s00705-017-3538.
    PubMed     Abstract available
    
    
    July 2017
94. YOUSSEF SS, Hamdy NM
    SOCS1 and pattern recognition receptors: TLR9 and RIG-I; novel haplotype associations in Egyptian fibrotic/cirrhotic patients with HCV genotype 4.
    Arch Virol. 2017 Jul 31. doi: 10.1007/s00705-017-3498.
    PubMed     Abstract available
    
    
    
95. DAUD M, Rana MA, Husnain T, Ijaz B, et al
    Modulation of Wnt signaling pathway by hepatitis B virus.
    Arch Virol. 2017 Jul 6. doi: 10.1007/s00705-017-3462.
    PubMed     Abstract available
    
    
    June 2017
96. ELHELW DS, Riad SE, Shawer H, El-Ekiaby N, et al
    Ectopic delivery of miR-200c diminishes hepatitis C virus infectivity through transcriptional and translational repression of Occludin.
    Arch Virol. 2017 Jun 22. doi: 10.1007/s00705-017-3449.
    PubMed     Abstract available
    
    
    
97. QU C, Xu L, Yin Y, Peppelenbosch MP, et al
    Nucleoside analogue 2'-C-methylcytidine inhibits hepatitis E virus replication but antagonizes ribavirin.
    Arch Virol. 2017 Jun 16. doi: 10.1007/s00705-017-3444.
    PubMed     Abstract available
    
    
    
98. LI S, Xie M, Li W, Peng Q, et al
    Prevalence of S gene mutations within the major hydrophilic region of hepatitis B virus in patients in Dongguan, southern China.
    Arch Virol. 2017 Jun 9. doi: 10.1007/s00705-017-3437.
    PubMed     Abstract available
    
    
    May 2017
99. CATTOIR L, Van Hoecke F, Van Maerken T, Nys E, et al
    Hepatitis E virus serology and PCR: does the methodology matter?
    Arch Virol. 2017 May 18. doi: 10.1007/s00705-017-3395.
    PubMed     Abstract available
    
    
    April 2017
100. RODRIGUEZ LAY LLA, Bello Corredor M, Montalvo Villalba MC, Chibas Ojeda AG, et al
     Hepatitis B virus infection assessed 3 to 18 years after vaccination in Cuban children and adolescents born to HBsAg-positive mothers.
     Arch Virol. 2017 Apr 24. doi: 10.1007/s00705-017-3365.
     PubMed     Abstract available
     
     
     
101. MORSICA G, Andolina A, Merli M, Messina E, et al
     NS3 protease resistance-associated substitutions in liver tissue and plasma samples from patients infected by hepatitis C virus genotype 1A or 1B.
     Arch Virol. 2017 Apr 18. doi: 10.1007/s00705-017-3341.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: